Prognostic factors in glioblastoma patients treated with the nitrosourea fotemustine at first relapse after the Stupp regimen: results from the GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology)
Matteo Santoni(University of Macerata), Roberta Rudà, Antonio Silvani, Andrea Pietro Sponghini(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Ivan Lolli(Gastroenterology Hospital "Saverio de Bellis"), Marina Faedi(Inserm), Veronica Villani(Istituti di Ricovero e Cura a Carattere Scientifico), Simona Vallarelli, Stefano Cascinu(Vita-Salute San Raffaele University), Maurizio Salvati, Maria Grazia Fabrini, F. Imbesi, Giuseppe Lombardi(University of Pisa), Manuela Caroli, Riccardo Soffietti(Azienda Ospedaliero Universitaria San Giovanni Battista), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Alfredo Marinelli(University of Naples Federico II), Silvia Scoccianti, M. Balducci(Agostino Gemelli University Polyclinic), Mauro Arcicasa
Cited by 0
Related Papers
Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
|Journal of Clinical Oncology|2010|2k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
|Annals of Oncology|2022|1.4k
Response assessment criteria for brain metastases: proposal from the RANO group
|The Lancet Oncology|2015|1.1k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k